1. Home
  2. EQIX vs SNY Comparison

EQIX vs SNY Comparison

Compare EQIX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equinix Inc. REIT

EQIX

Equinix Inc. REIT

HOLD

Current Price

$1,092.66

Market Cap

107.0B

Sector

Real Estate

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$42.34

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQIX
SNY
Founded
1998
1994
Country
United States
France
Employees
N/A
74846
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.0B
104.5B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EQIX
SNY
Price
$1,092.66
$42.34
Analyst Decision
Strong Buy
Buy
Analyst Count
24
5
Target Price
$1,076.87
$58.00
AVG Volume (30 Days)
534.6K
3.5M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
1.90%
3.47%
EPS Growth
61.88
N/A
EPS
4.20
N/A
Revenue
$5,998,545,000.00
N/A
Revenue This Year
$12.35
$3.49
Revenue Next Year
$8.88
$6.10
P/E Ratio
$258.33
$6.14
Revenue Growth
7.85
N/A
52 Week Low
$720.62
$40.89
52 Week High
$1,128.68
$52.68

Technical Indicators

Market Signals
Indicator
EQIX
SNY
Relative Strength Index (RSI) 55.06 43.39
Support Level $1,042.67 $42.30
Resistance Level $1,097.77 $48.76
Average True Range (ATR) 26.27 0.73
MACD 2.33 -0.15
Stochastic Oscillator 66.59 35.86

Price Performance

Historical Comparison
EQIX
SNY

About EQIX Equinix Inc. REIT

Equinix is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and businesses. Equinix operates 270 properties in 77 metropolitan areas across 36 countries, serving over 10,000 customers. About 70% of Equinix's revenue comes from renting physical space, which allows hyperscalers and other clients to store servers, data storage, and networking equipment. The other 30% of revenue is generated primarily through interconnection services (20%) and other managed services (10%).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: